Literature DB >> 31201730

A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Pedro L Ferreira1,2, Patrícia Antunes1, Lara N Ferreira3,4,5, Luís N Pereira1,6,7, Juan M Ramos-Goñi8.   

Abstract

BACKGROUND: The EQ-5D is a generic preference-based quality of life measure considered useful for supporting clinical and policy decisions by providing utility values that can easily be converted into quality-adjusted life years to be integrated in cost-utility economic evaluations. Although the three-level classification system of the EuroQol questionnaire (EQ-5D-3L) is still the most popular preference-based instrument used worldwide, several studies reported a ceiling effect on this version, especially in healthy and/or young individuals. In 2009, the EuroQol Group introduced a five-level EQ-5D, which expands the descriptive system from three to five levels within the same five dimensions. For this version to be used in health economic evaluation, societal values need to be assigned to the 3125 health states generated by this instrument.
OBJECTIVES: The aims of this study were to elicit the EQ-5D-5L health state preferences from the general Portuguese population and to derive the Portuguese value set for the EQ-5D-5L.
METHODS: A representative sample of the Portuguese general population aged above 18 years was stratified by age and gender (n = 1451). Between October 2015 and July 2016, 28 interviewers carried out a series of 1-h-long computer-assisted personal interviews following the EuroQol Valuation Technology protocol. Each interview included the valuation of ten health states using the composite time trade-off (cTTO) and seven pairs of discrete choice experiments (DCEs). A standardized tool for quality control was used to assess the quality of the data as well as direct supervision and cross-examination of 10% of the global sample size. Data from both cTTO and DCE valuation tasks were modelled using a censored heteroskedastic hybrid model.
RESULTS: Interviewers complied with the quality control protocol in providing high-quality valuation data. The hybrid econometric model had consistent and significant parameters. The derived societal values for the Portuguese population ranged from - 0.603 to 1.
CONCLUSION: This study provided the Portuguese value set for the EQ-5D-5L on the basis of a hybrid econometric model using cTTO and DCE data. These results represent the preferences of the Portuguese population and are recommended to inform health decision-making in Portugal.

Entities:  

Keywords:  Composite time trade-off; Discrete choice experiment; EQ-5D-5L; Portuguese value set; Preferences; Quality of life

Mesh:

Year:  2019        PMID: 31201730     DOI: 10.1007/s11136-019-02226-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  47 in total

1.  Correcting biases in standard gamble and time tradeoff utilities.

Authors:  Sylvie M C van Osch; Peter P Wakker; Wilbert B van den Hout; Anne M Stiggelbout
Journal:  Med Decis Making       Date:  2004 Sep-Oct       Impact factor: 2.583

2.  A comparison of alternative variants of the lead and lag time TTO.

Authors:  Nancy Devlin; Ken Buckingham; Koonal Shah; Aki Tsuchiya; Carl Tilling; Grahame Wilkinson; Ben van Hout
Journal:  Health Econ       Date:  2012-06-19       Impact factor: 3.046

3.  Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences?

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Health Econ       Date:  2006-08       Impact factor: 3.046

4.  Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese Population.

Authors:  Cindy L K Lam; John Brazier; Sarah M McGhee
Journal:  Value Health       Date:  2008 Mar-Apr       Impact factor: 5.725

5.  Estimating the SF-6D value set for a population-based sample of Brazilians.

Authors:  Luciane N Cruz; Suzi A Camey; Juliana F Hoffmann; Donna Rowen; John E Brazier; Marcelo P Fleck; Carisi A Polanczyk
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

6.  Quality Control Process for EQ-5D-5L Valuation Studies.

Authors:  Juan M Ramos-Goñi; Mark Oppe; Bernhard Slaap; Jan J V Busschbach; Elly Stolk
Journal:  Value Health       Date:  2016-12-22       Impact factor: 5.725

Review 7.  Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.

Authors:  Elly Stolk; Kristina Ludwig; Kim Rand; Ben van Hout; Juan Manuel Ramos-Goñi
Journal:  Value Health       Date:  2019-01-02       Impact factor: 5.725

8.  Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.

Authors:  Juan M Ramos-Goñi; Benjamin M Craig; Mark Oppe; Yolanda Ramallo-Fariña; Jose Luis Pinto-Prades; Nan Luo; Oliver Rivero-Arias
Journal:  Value Health       Date:  2017-12-02       Impact factor: 5.725

9.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

10.  Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues.

Authors:  Nick Bansback; Arne Risa Hole; Brendan Mulhern; Aki Tsuchiya
Journal:  Soc Sci Med       Date:  2014-05-20       Impact factor: 4.634

View more
  17 in total

1.  EQ-5D-5L: a value set for Romania.

Authors:  Elena Olariu; Wael Mohammed; Yemi Oluboyede; Raluca Caplescu; Ileana Gabriela Niculescu-Aron; Marian Sorin Paveliu; Luke Vale
Journal:  Eur J Health Econ       Date:  2022-06-10

2.  A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.

Authors:  Donna Rowen; Clara Mukuria; Emily McDool
Journal:  Pharmacoeconomics       Date:  2022-07-13       Impact factor: 4.558

3.  The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data.

Authors:  Cathrine Elgaard Jensen; Sabrina Storgaard Sørensen; Claire Gudex; Morten Berg Jensen; Kjeld Møller Pedersen; Lars Holger Ehlers
Journal:  Appl Health Econ Health Policy       Date:  2021-02-02       Impact factor: 2.561

4.  Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment.

Authors:  Pedro L Ferreira; Isabel Luzeiro; Margarida Lopes; André Jorge; Bruno Silva; Lara Ferreira
Journal:  BMC Neurol       Date:  2021-02-06       Impact factor: 2.474

5.  The EQ-5D-5L Valuation Study in Egypt.

Authors:  Sahar A Al Shabasy; Maggie M Abbassi; Aureliano Paolo Finch; Darrin Baines; Samar F Farid
Journal:  Pharmacoeconomics       Date:  2021-03-12       Impact factor: 4.981

6.  Anxiety levels moderate the association between visual acuity and health-related quality of life in chronic eye disease patients.

Authors:  Hugo Senra; Laura Hernandez-Moreno; Natacha Moreno; António Filipe Macedo
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

7.  Properties of the EQ-5D-5L when prospective longitudinal data from 28,902 total hip arthroplasty procedures are applied to different European EQ-5D-5L value sets.

Authors:  Anders Joelson; Peter Wildeman; Freyr Gauti Sigmundsson; Ola Rolfson; Jan Karlsson
Journal:  Lancet Reg Health Eur       Date:  2021-07-14

8.  The EQ-5D-5L Valuation Study in Egypt.

Authors:  Sahar Al Shabasy; Maggie Abbassi; Aureliano Finch; Bram Roudijk; Darrin Baines; Samar Farid
Journal:  Pharmacoeconomics       Date:  2021-11-17       Impact factor: 4.558

9.  Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL).

Authors:  Pedro Lopes Ferreira; Margarida Gonçalo; José Alberto Ferreira; Ana Célia Costa; Ana Todo-Bom; Cristina Lopes Abreu; Ana Rita Travassos; Pedro Andrade; Ilaria Baiardini; Giorgio Walter Canonica
Journal:  Health Qual Life Outcomes       Date:  2019-12-30       Impact factor: 3.186

10.  Quality of life under the COVID-19 quarantine.

Authors:  Lara N Ferreira; Luís N Pereira; Maria da Fé Brás; Kateryna Ilchuk
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.